Back to Results
First PageMeta Content
Medicine / Hepatitis C virus / Cytokines / Antiviral drug / Microbiology / Hepatitis C / Virus / Ribavirin / NS5 / Antivirals / Biology / Hepatitis


Document Date: 2014-09-18 02:00:41

Open Document

File Size: 245,81 KB

Share Result on Facebook

Country

United States / Canada / /

Facility

HCV Drug pipeline / /

IndustryTerm

main replication site / treatment of HCV / HCV therapy / printing presses / food / /

MedicalCondition

HIV / HBV / hepatitis C / HCV / virus infection / diseases / Benefits Column ¾¾ Hepatitis B / hepatitis C. We / hepatitis C. It / /

Person

Alan Franciscus Webmaster / C.D. Mazoff / Lucinda K. Porter / /

Position

Editor-in-Chief / ¾¾ HCV Advocate / BASICS Executive Director / HCV Advocate / HBV Advocate / Webmaster / /

Product

ribavirin / peginterferon / /

URL

www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html / www.hcvadvocate.org / www.clinicaltrials.gov / /

SocialTag